BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruzzenente A, Bagante F, Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Koerkamp BG, Jarnagin WR, Nadalin S, Pratschke J, Schmelzle M, Sparrelid E, Lang H, Iacono C, van Gulik TM, Guglielmi A; Perihilar Cholangiocarcinoma Collaboration Group. Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group. Ann Surg Oncol 2021. [PMID: 33956275 DOI: 10.1245/s10434-021-09905-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Alaimo L, Bagante F, Ruzzenente A. The Role of Surgery in the Treatment of Bismuth-Corlette Type IV Perihilar Cholangiocarcinoma. Ann Surg Oncol 2021. [PMID: 33881654 DOI: 10.1245/s10434-021-09980-2] [Reference Citation Analysis]
2 Nooijen LE, Banales JM, de Boer MT, Braconi C, Folseraas T, Forner A, Holowko W, Hoogwater FJH, Klümpen H, Groot Koerkamp B, Lamarca A, La Casta A, López-lópez F, Izquierdo-sánchez L, Scheiter A, Utpatel K, Swijnenburg R, Kazemier G, Erdmann JI. Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry. Cancers 2022;14:2389. [DOI: 10.3390/cancers14102389] [Reference Citation Analysis]
3 Macias RIR, Cardinale V, Kendall TJ, Avila MA, Guido M, Coulouarn C, Braconi C, Frampton AE, Bridgewater J, Overi D, Pereira SP, Rengo M, Kather JN, Lamarca A, Pedica F, Forner A, Valle JW, Gaudio E, Alvaro D, Banales JM, Carpino G. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut 2022:gutjnl-2022-327099. [PMID: 35580963 DOI: 10.1136/gutjnl-2022-327099] [Reference Citation Analysis]